RFK Jr. and Dr. Oz just pulled the federal plug on gender-affirming care for minors, yanking billions in funding to shield kids from what they call medical malpractice.
Story Snapshot
- HHS Secretary RFK Jr. and CMS head Dr. Oz lead multi-agency push to halt puberty blockers, hormones, and surgeries for transgender youth nationwide.
- Federal funding cuts force Medicare/Medicaid hospitals to drop these procedures, overriding even protective state laws.
- FDA targets chest binders with warning letters; HHS redefines gender dysphoria outside disability protections.
- Press conference on December 18, 2025, unites RFK Jr., Oz, FDA’s Makary, and NIH’s Bhattacharya against youth transitions.
- Move echoes 27 state bans and Supreme Court backing, prioritizing child protection over medical consensus.
Press Conference Unveils Federal Crackdown
Robert F. Kennedy Jr., HHS Secretary, stood with CMS Administrator Dr. Mehmet Oz, FDA head Dr. Marty Makary, and NIH representative Dr. Jay Bhattacharya at a Washington, D.C. press conference on December 18, 2025. They announced rules barring Medicare- and Medicaid-participating hospitals from gender-transition procedures on minors. RFK Jr. labeled these interventions malpractice that robs children of their futures. The coalition targets federal funding to enforce nationwide restrictions.
Hospitals face a stark choice: cease care for transgender youth or forfeit vital federal reimbursements. This leverages America’s reliance on Medicare and Medicaid, affecting nearly every major facility. States protecting such care see their policies undercut, as federal dollars dictate practice.
Core Measures Dismantle Access Nationwide
CMS under Dr. Oz prohibits federal Medicaid funds from covering puberty blockers, cross-sex hormones, or surgeries for minors. Participating hospitals must comply or risk exclusion from programs serving millions. HHS Office for Civil Rights proposes excluding gender dysphoria from federal disability definitions, stripping related protections. These steps create a functional ban without new statutes.
FDA issues warning letters to a dozen companies marketing chest binders for gender dysphoria. Regulators insist devices carry approved indications only, like post-mastectomy recovery. Off-label promotion for minors triggers enforcement, closing another access avenue. This regulatory precision aligns with conservative priorities of evidence-based medicine over ideology.
Backdrop of State Bans and Judicial Wins
Twenty-seven states already restrict gender-affirming care for minors, criminalizing providers or blocking Medicaid in places like Tennessee and Florida. The Supreme Court upheld Tennessee’s ban, affirming states’ rights to protect youth from irreversible procedures. Federal action fills gaps in blue states, where sanctuary laws shielded trans youth travel for care. Common sense demands national standards when kids’ bodies hang in the balance.
Medical groups like the American Academy of Pediatrics endorse these treatments as evidence-based. Yet RFK Jr.’s team cites long-term harms, echoing European nations like Sweden and the UK that curtailed youth transitions after reviews found weak evidence. This shift prioritizes caution, resonating with American values of parental rights and bodily integrity.
Immediate Fallout and Long-Term Shifts
Hospitals scramble to suspend appointments, freezing ongoing treatments and sparking mental health concerns for affected youth. Families face out-of-pocket costs or underground options, while providers weigh ethics against funding survival. Legal challenges loom from advocacy groups, testing rules in courts already sympathetic to restrictions.
Long-term, research on youth gender care may dwindle under scrutiny, reshaping training and standards. This precedent equips regulators to tackle other disputes, like reproductive care, via funding levers. Politically, it rallies conservatives while igniting overreach debates. Facts support protecting minors from experimental paths with lifelong consequences.
Sources:
RFK Jr. announces moves to ban gender-affirming care for young people
